La reactividad plaquetaria post-tratamiento predice los eventos adversos a largo plazo mejor que la respuesta al clopidogrel en pacientes con síndrome coronario agudo sin elevación del ST-Reference-Cited by-同舟云学术

La reactividad plaquetaria post-tratamiento predice los eventos adversos a largo plazo mejor que la respuesta al clopidogrel en pacientes con síndrome coronario agudo sin elevación del ST

Published:2009-02 Issue:2 Volume:62 Page:126-135
ISSN:0300-8932
Container-title:Revista Española de Cardiología
language:es
Short-container-title:Revista Española de Cardiología

Author:

de Miguel Castro Antonio,Cuellas Ramón Carlos,Diego Nieto Alejandro,Samaniego Lampón Beatriz,Alonso Rodríguez David,Fernández Vázquez Felipe,Alonso Orcajo Norberto,Carbonell de Blas Raúl,Pascual Vicente Cristina,Pérez de Prado Armando

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med,2001

2. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial;Steinhubl;JAMA,2002

3. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCICURE study;Mehta;Lancet,2001

4. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease;Gum;J Am Coll Cardiol,2003

5. Aspirin and clopidogrel resistance: Consideration and management;Gurbel;J Interv Cardiol,2006

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting ischaemic events using platelet reactivity in patients receiving clopidogrel: Indirect meta‐comparison among VerifyNow, light transmission aggregometry and thromboelastography;Basic & Clinical Pharmacology & Toxicology;2020-06-12

2. No Differences in Levels of Circulating Progenitor Endothelial Cells or Circulating Endothelial Cells Among Patients Treated With Ticagrelor Compared With Clopidogrel During Non–ST‐Segment–Elevation Myocardial Infarction;Journal of the American Heart Association;2018-10-02

3. C3435T polymorphism of the ABCB1 gene is associated with poor clopidogrel responsiveness in a Mexican population undergoing percutaneous coronary intervention;Thrombosis Research;2015-11

4. High post-clopidogrel platelet reactivity assessed by a point-of-care assay predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who underwent primary coronary stenting;International Journal of Cardiology;2013-09

5. Triple antiplatelet therapy with addition of cilostazol to aspirin and clopidogrel for Y-stent-assisted coil embolization of cerebral aneurysms;Acta Neurochirurgica;2013-05-29